BMC ophthalmology

Sudden vision nerve damage possibly linked to semaglutide treatment: report of four cases

Updated

Abstract

Four male patients developed (NAION) during treatment with semaglutide, with three cases having treatment durations of less than one year.

  • All patients exhibited significant optic disc swelling and fluid in the retina as seen on imaging.
  • Three patients had small openings in Bruch's membrane, measuring less than 1.4 mm.
  • One patient showed optic disc drusen, a condition often linked with visual impairment.
  • Visual field defects were related to loss of ganglion cells, indicating potential damage to the optic nerve.
  • Systemic risk factors varied among patients; two were only obese.

Simplified

Key numbers

3 of 4
Diameter < 1.4 mm
measurements in affected patients
18 kg
Weight Loss
Weight loss achieved by Case 1 after 11 months on semaglutide

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declarations. Ethics approval and consent to participate: Ethics committee approval was not required as the study utilized data obtained through standard patient care practices. The authors declare that they adhered to the CARE guidelines/methodology. Consent for publication: Informed written consent for publication was obtained from the patients. Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free